Article
IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy.
Journal of neuro-oncology - 1 Sept 2018
Uckermann Ortrud, Yao Wenmin, Juratli Tareq A, Galli Roberta, Leipnitz Elke, Meinhardt Matthias, Koch Edmund, Schackert Gabriele, Steiner Gerald, Kirsch Matthias
Abstract excerpt
INTRODUCTION: Mutations in the isocytrate dehydrogenase 1 (IDH1) gene are early genetic events in glioma pathogenesis and cause profound metabolic changes. Because this genotype is found in virtually every tumor cell, therapies targeting mutant IDH1 protein are being developed. The intraoperative administration of those therapies would require fast technologies for the determination of IDH1 genotype. As of today,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
